Ross Muken
Stock Analyst at Evercore ISI Group
(2.76)
# 1,929
Out of 5,111 analysts
47
Total ratings
61.54%
Success rate
4.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $190 → $200 | $198.15 | +0.93% | 9 | Oct 3, 2025 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $77.39 | -9.55% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $184.37 | +30.17% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $140.60 | -7.54% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $45.44 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $199.96 | -66.49% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $134.92 | +85.29% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $575.91 | -61.80% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $10.54 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Oct 3, 2025
Maintains: Outperform
Price Target: $190 → $200
Current: $198.15
Upside: +0.93%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $77.39
Upside: -9.55%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $184.37
Upside: +30.17%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $140.60
Upside: -7.54%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $45.44
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $199.96
Upside: -66.49%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $134.92
Upside: +85.29%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $575.91
Upside: -61.80%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $10.54
Upside: -